Lauder Q1: Firm Discusses China Tariff Uncertainties, Imminent Clinique Customization Launch
This article was originally published in The Rose Sheet
Executive Summary
The firm is confident that prestige beauty demand in China will remain a constant, translating to double-digit growth over the long term, but it’s taking a prudent approach to guidance in light of possible tariff impacts, among other unknowns. Lauder’s first-quarter sales totaled $3.52bn, up 11% in organic terms.
You may also be interested in...
Lauder Investing In Americas Turnaround While Asia/Pacific Continues To Soar
Prestige skin care continues to win big with young Chinese consumers, and makeup demand is picking up, according to Lauder leadership. Overall, the firm’s Asia/Pacific sales climbed 17%, reported, to $1.02bn, helping to offset continued declines in the Americas.
L’Oreal: 2018 Nine-Month Results Clearly Show ‘It’s Not The End Of The Big Brands’
Luxury beauty growth shows no signs of slowing, and L’Oreal markets some heavy hitters in the luxury tier. But L’Oreal Paris, Maybelline and other big names within the firm’s Consumer division also are having a superb year, with one noted exception.
Cosmetics Industry, Consumers Will Lose Under Latest Tariff Proposal In US-China Feud
The Personal Care Products Council says US-proposed tariffs on an additional $200bn of Chinese products, including a wide range of cosmetics and vital materials, will undermine American companies’ competitiveness and pass costs along to consumers. The group’s Executive VP-Global Strategies Francine Lamoriello testified on the matter in an Aug. 23 public hearing held by the US Trade Representative.